Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Part of paid clinical trials in San Diego, California.
- Sponsor
- Blue Earth Diagnostics
- Study ID
- NCT07569926
- Phase
- PHASE4
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- fluciclovine (18F) — DRUGfluciclovine (18F) injection, 370 MBq (10 mCi) ± 20%, delivered as an intravenous bolus.
Study Details
The impact of fluciclovine (18F) PET on the management of participants with prostate cancer following negative or equivocal PSMA PET Imaging at the time of biochemical recurrence
Key Dates
- First listed
- May 6, 2026
- Start date
- Aug 31, 2026
- Status verified
- Sep 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2032
Study Design
- Enrollment
- 142 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Patients Single intravenous administration of fluciclovine (18F) for PET ScanPatients Single intravenous administration of fluciclovine (18F) for PET Scan
Primary Outcome Measure
Percentage of participants with any recorded Change In Management following a fluciclovine (18F) PET/CT scan. [ Time Frame: fluciclovine (18F) on Day 1, At least 24 hours after the piflufolastat (18F) scan, but within 30 calendar days ]
Central Contacts
- BED-Flc-401 Study Team+44 (0) 1865 507300
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Diego Health | San Diego | California | 92103 | Sherief H Gamie, MD |
| Emory University | Atlanta | Georgia | 30322 | Ismaheel Lawal, MD |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Pedram Heidari, MD |
| Washington University | St Louis | Missouri | 63110 | Ashwin Parihar, MD |
| Oregon Health & Science University | Portland | Oregon | 97239 | Nadine Mallak, MD |
| Urology Austin | Austin | Texas | 78759 | Brian Mazzarella, MD |
Find similar trials in San Diego, CA
Nationwide
By condition
By specialty
Related Studies
- Active Surveillance for Cancer of the Prostate (ASCaP)Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical ProstatectomyRecruiting · Proton Collaborative Group · Little Rock, Arkansas
- Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing ProstatectomyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado